Bright-field HER2 dual in situ hybridization (DISH) assay on breast cancer cell blocks: a comparative study with histological sections

被引：0
|
作者：
Rieko Nishimura
Nami Okamoto
Masakazu Satou
Kenta Kojima
Shinichi Tanaka
Natsumi Yamashita
机构：
[1] National Hospital Organization Shikoku Cancer Center,Department of Clinical Laboratory
[2] National Hospital Organization Shikoku Cancer Center,Division of Clinical Biostatistics, Section of Cancer Prevention and Epidemiology, Clinical Research Center
来源：
Breast Cancer | 2016年 / 23卷
关键词：
Breast cancer; Cytology; Cell block; gene; DISH;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：917 / 921
页数：4
相关论文
共 50 条
  • [41] The role of serum HER2 as an alternative to fluorescence in situ hybridization for HER2 in metastatic breast cancer.
    Kong, SY
    Kwon, Y
    Lee, DH
    Lee, JS
    Lee, ES
    Ro, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 48S - 48S
  • [42] Gold-facilitated in situ hybridization -: A bright-field autometallographic alternative to fluorescence in situ hybridization for detection of HER-2/neu gene amplification
    Tubbs, R
    Pettay, J
    Skacel, M
    Powell, R
    Stoler, M
    Roche, P
    Hainfeld, J
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (05): : 1589 - 1595
  • [43] Bright-field In Situ Hybridization for HER2 Gene Amplification in Breast Cancer Using Tissue Microarrays Correlation Between Chromogenic (CISH) and Automated Silver-enhanced (SISH) Methods With Patient Outcome
    Francis, Glenn D.
    Jones, Mark A.
    Beadle, Geoffrey F.
    Stein, Sandra R.
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2009, 18 (02) : 88 - 95
  • [44] Comparison of HER2 Dual-Color and Fluorescence In Situ Hybridization in Breast Cancer A Cohort Study Emphasizing Equivocal Cases
    Shao, Tiffany
    Wood, Martha
    Wing, Anthony
    Hnatovska, Marta
    Mendes, Maria
    Mullen, J. Brendan
    Chang, Martin C.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (03) : 339 - 345
  • [45] The Correlation Between Dual-color Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization in Assessing HER2 Gene Amplification in Breast Cancer
    Pedersen, Marianne
    Rasmussen, Birgitte Bruun
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2009, 18 (02) : 96 - 102
  • [46] HER-2/Neu Status Can Be Reliably Determined in Cytologic Breast Cancer Specimens Using Bright-Field Microscopy and Silver In-Situ Hybridization (SISH)
    Ghorab, Z.
    Saad, R. S.
    Noy, S.
    Hanna, W. M.
    Nofech-Mozes, S.
    LABORATORY INVESTIGATION, 2011, 91 : 91A - 91A
  • [47] HER-2/Neu Status Can Be Reliably Determined in Cytologic Breast Cancer Specimens Using Bright-Field Microscopy and Silver In-Situ Hybridization (SISH)
    Ghorab, Z.
    Saad, R. S.
    Noy, S.
    Hanna, W. M.
    Nofech-Mozes, S.
    MODERN PATHOLOGY, 2011, 24 : 91A - 91A
  • [48] Development of an easy method to test for HER2 in breast cancer using dual-color in situ hybridization
    Nakagawa, Tomoe
    Horii, Rie
    Ito, Yoshinori
    Iwase, Takuji
    Akiyama, Futoshi
    BREAST CANCER, 2016, 23 (01) : 78 - 84
  • [49] Development of an easy method to test for HER2 in breast cancer using dual-color in situ hybridization
    Tomoe Nakagawa
    Rie Horii
    Yoshinori Ito
    Takuji Iwase
    Futoshi Akiyama
    Breast Cancer, 2016, 23 : 78 - 84
  • [50] Instant-quality fluorescence in-situ hybridization as a new tool for HER2 testing in breast cancer: a comparative study
    Franchet, Camille
    Filleron, Thomas
    Cayre, Anne
    Mounie, Eveline
    Penault-Llorca, Frederique
    Jacquemier, Jocelyne
    MacGrogan, Gaetan
    Arnould, Laurent
    Lacroix-Triki, Magali
    HISTOPATHOLOGY, 2014, 64 (02) : 274 - 283
12345